Novartis AG (NVS) Stock Overview
Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.
Novartis AG (NVS)
Key Financials
Key Financials
Market Cap
296.3B
P/E Ratio
22.15
EPS (TTM)
$8.69
ROE
0.32%
NVS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $170.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.15 and a market capitalization of 296.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.